EOLS
NASDAQ · Pharmaceuticals
Evolus Inc
$5.84
-0.17 (-2.83%)
Open$6.01
Previous Close$6.01
Day High$6.01
Day Low$5.72
52W High$7.95
52W Low$3.86
Volume—
Avg Volume912.9K
Market Cap510.24M
P/E Ratio—
EPS$-0.67
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+778.3% upside
Current
$5.84
$5.84
Target
$51.29
$51.29
$37.24
$51.29 avg
$70.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 402.74M | 319.66M | 74.40M |
| Net Income | -69,983,208 | -49,991,973 | 20.76M |
| Profit Margin | -17.4% | -16.5% | 27.9% |
| EBITDA | -35,760,458 | -26,964,390 | 38.85M |
| Free Cash Flow | — | — | 15.01M |
| Rev Growth | +26.0% | +26.0% | +16.8% |
| Debt/Equity | 22.00 | 22.00 | 0.90 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |